Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 26 April 2016 Biocartis Strengthens Biomarker Portfolio for Colorectal Cancer Exclusive license of recently detected EGFR resistance mutations Non-regulated information 3 February 2016 Biocartis & Amgen Collaborate to Offer Rapid RAS Biomarker Testing to Selected Hospitals and Clinics... Non-regulated information 7 January 2016 Biocartis & Merck to Collaborate on New Liquid Biopsy Technology for RAS Biomarker Testing Non-regulated information 22 December 2015 Biocartis launches world’s first fully automated liquid biopsy assay and its second tissue assay for colorectal cancer Launch of two new tests on its Idylla™ molecular diagnostics platform strengthens the company’s assay menu Non-regulated information 16 December 2015 Biocartis announces financial calendar 2016 Non-regulated information 30 November 2015 Biocartis announces launch of Influenza-Respiratory Virus Panel on the Idylla™ platform Non-regulated information 3 November 2015 Biocartis participate in key IR conferences in November 2015 Non-regulated information 27 October 2015 Biocartis receives € 1.4M grant for development of innovative liquid biopsy tests Non-regulated information 24 June 2015 Biocartis’ KRAS Mutation Test receives CE-IVD marking Non-regulated information Pagination First page « First Previous page ‹‹ … Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11